<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Elderly Patients &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/elderly-patients/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 25 Jan 2026 09:39:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Elderly Patients &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Low Albumin and B-cell Subtype Predicting Lymphoma Outcomes</title>
		<link>https://bioengineer.org/low-albumin-and-b-cell-subtype-predicting-lymphoma-outcomes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 25 Jan 2026 09:39:03 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[B-cell subtype]]></category>
		<category><![CDATA[Elderly Patients]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 etiket (virgülle ayrılmış): **Large B-cell lymphoma]]></category>
		<category><![CDATA[Prognostic factors** **Açıklama:** 1. **Large B-cell lymphoma:** Makalenin ana konusu olan lenfoma tipi. 2. **Elderly patients:** Araştırmanın özel olarak odaklandığı]]></category>
		<category><![CDATA[Serum albumin]]></category>
		<guid isPermaLink="false">https://bioengineer.org/low-albumin-and-b-cell-subtype-predicting-lymphoma-outcomes/</guid>

					<description><![CDATA[In a significant development in the field of hematology, researchers have pinpointed critical prognostic factors for elderly patients suffering from large B-cell lymphoma (LBCL). This study, which highlights the relationship between low serum albumin levels and the specific B-cell subtypes as identified by the Hans algorithm, opens new avenues for personalized treatment strategies in patients [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320653</post-id>	</item>
		<item>
		<title>Acute Pain Mediates Dexmedetomidine’s Effects on Elderly Outcomes</title>
		<link>https://bioengineer.org/acute-pain-mediates-dexmedetomidines-effects-on-elderly-outcomes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 06 Jan 2026 01:12:49 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[ameliyat sonrası ağrı]]></category>
		<category><![CDATA[Dexmedetomidine]]></category>
		<category><![CDATA[Elderly Patients]]></category>
		<category><![CDATA[gastrointestinal cerrahi** **Açıklama:** 1. **dexmedetomidine:** Çalışmanın ana konusu olan ilaç. 2.]]></category>
		<category><![CDATA[Gastrointestinal surgery]]></category>
		<category><![CDATA[İşte 5 uygun etiket (virgülle ayrılmış): **dexmedetomidine]]></category>
		<category><![CDATA[Neuropsychiatric Outcomes]]></category>
		<category><![CDATA[nöropsikiyatrik sonuçlar]]></category>
		<category><![CDATA[Postoperative Pain]]></category>
		<category><![CDATA[yaşlı cerrahi hastaları]]></category>
		<guid isPermaLink="false">https://bioengineer.org/acute-pain-mediates-dexmedetomidines-effects-on-elderly-outcomes/</guid>

					<description><![CDATA[In the evolving landscape of surgical procedures, the utilization of dexmedetomidine during operations has garnered significant attention, particularly in the context of its effects on postoperative recovery. A recent multicenter observational study led by Lv and colleagues sheds light on the crucial intersection between acute postoperative pain, intraoperative dexmedetomidine, and neuropsychiatric outcomes in elderly patients [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">313961</post-id>	</item>
		<item>
		<title>Intraoperative Hypotension’s Impact on Kidney Injury in Seniors</title>
		<link>https://bioengineer.org/intraoperative-hypotensions-impact-on-kidney-injury-in-seniors/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 31 Dec 2025 09:21:34 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[acute kidney injury]]></category>
		<category><![CDATA[Elderly Patients]]></category>
		<category><![CDATA[İşte bu içerik için en uygun 5 etiket: **intraoperative hypotension]]></category>
		<category><![CDATA[noncardiac surgery]]></category>
		<guid isPermaLink="false">https://bioengineer.org/intraoperative-hypotensions-impact-on-kidney-injury-in-seniors/</guid>

					<description><![CDATA[In a significant exploration of the effects of intraoperative hypotension on postoperative health, a recent cohort study has provided compelling evidence linking hypotension—a common occurrence during surgery—to acute kidney injury (AKI) in elderly patients undergoing noncardiac procedures. The research, conducted by Liu et al., sheds light on a critical aspect of surgical medicine that merits [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">312563</post-id>	</item>
		<item>
		<title>Understanding CKD and Anticoagulation Risks in Seniors</title>
		<link>https://bioengineer.org/understanding-ckd-and-anticoagulation-risks-in-seniors/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 28 Dec 2025 10:57:00 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Anticoagulation Risks]]></category>
		<category><![CDATA[Antikoagülasyon reçetele]]></category>
		<category><![CDATA[Atrial Fibrillation]]></category>
		<category><![CDATA[Bleeding Complications]]></category>
		<category><![CDATA[Böbrek hastalığında kanama riski]]></category>
		<category><![CDATA[Chronic Kidney Disease]]></category>
		<category><![CDATA[Elderly Patients]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 adet Türkçe etiket (virgülle ayrılmış): **Kronik böbrek hastalığı ve atriyal fibrilasyon]]></category>
		<category><![CDATA[Yaşlı hastalarda AF yönetimi]]></category>
		<category><![CDATA[Yaşlılarda antikoagülasyon tedavisi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/understanding-ckd-and-anticoagulation-risks-in-seniors/</guid>

					<description><![CDATA[The rising prevalence of chronic kidney disease (CKD) alongside atrial fibrillation (AF) in older adults has emerged as a significant health concern, necessitating focused research. In their recent study, Abu et al. systematically explored the intricate relationships between CKD, anticoagulation prescribing patterns, and the associated risks of major bleeding specifically among older patients with AF. [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">311898</post-id>	</item>
		<item>
		<title>Evaluating BioPMovQ’s Effectiveness in Elderly Pain Patients</title>
		<link>https://bioengineer.org/evaluating-biopmovqs-effectiveness-in-elderly-pain-patients/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 21 Dec 2025 03:00:05 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biyodavranışsal ağrı anketi]]></category>
		<category><![CDATA[chronic musculoskeletal pain]]></category>
		<category><![CDATA[Elderly Patients]]></category>
		<category><![CDATA[İşte bu içerik için en uygun 5 etiket: `BioPMovQ]]></category>
		<category><![CDATA[kronik kas-iskelet ağrısı]]></category>
		<category><![CDATA[kültürel uyarlanmış ağrı araçları]]></category>
		<category><![CDATA[pain assessment tools` **Kısa Açıklama:** 1. **BioPMovQ:** Araştırmanın merkezindeki ölçeğin adı]]></category>
		<category><![CDATA[psikometrik değerlendirme]]></category>
		<category><![CDATA[psychometric evaluation]]></category>
		<category><![CDATA[temel anahtar kelime. 2. **Psychometric evaluation:** Makalenin temel konusu ve]]></category>
		<category><![CDATA[yaşlı hasta ağrı yönetimi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/evaluating-biopmovqs-effectiveness-in-elderly-pain-patients/</guid>

					<description><![CDATA[Psychometric evaluation research has become increasingly critical in understanding and addressing the complex needs of elderly patients, particularly when it comes to chronic pain management. The recent study led by Kong et al. investigates the psychometric properties of the Chinese version of the biobehavioural pain and movement questionnaire, commonly referred to as the BioPMovQ. This [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">309977</post-id>	</item>
		<item>
		<title>Gradient Boosting Reveals Cost Drivers in Laparoscopic Surgery</title>
		<link>https://bioengineer.org/gradient-boosting-reveals-cost-drivers-in-laparoscopic-surgery/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 02 Dec 2025 19:44:29 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[araştırmanın amacını (Cost Drivers) ve genel bağlamını (Healthcare Economics) kapsayacak şekilde se]]></category>
		<category><![CDATA[Cost Drivers]]></category>
		<category><![CDATA[Elderly Patients]]></category>
		<category><![CDATA[Gradient Boosting Regression Trees]]></category>
		<category><![CDATA[Healthcare Economics *Bu etiketler makalenin temel konusunu (laparoskopik cerrahi ve yaşlı hastalar)]]></category>
		<category><![CDATA[kullanılan ana yöntemi (Gradient Boosting Regression Trees)]]></category>
		<category><![CDATA[Laparoscopic Surgery]]></category>
		<guid isPermaLink="false">https://bioengineer.org/gradient-boosting-reveals-cost-drivers-in-laparoscopic-surgery/</guid>

					<description><![CDATA[In a groundbreaking study conducted by Hu, Liu, and Liu, researchers have ventured into the intricate realm of healthcare economics, particularly focusing on laparoscopic surgery for elderly patients. This innovative investigation leverages advanced machine learning techniques, specifically gradient boosting regression trees, to discern the underlying cost drivers associated with these surgical procedures. The significance of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">304487</post-id>	</item>
		<item>
		<title>Serum Potassium Linked to 28-Day Sepsis Mortality</title>
		<link>https://bioengineer.org/serum-potassium-linked-to-28-day-sepsis-mortality/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 13 Nov 2025 00:37:02 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Elderly Patients]]></category>
		<category><![CDATA[Electrolyte Imbalance]]></category>
		<category><![CDATA[Sepsis Mortality]]></category>
		<category><![CDATA[Serum Potassium]]></category>
		<guid isPermaLink="false">https://bioengineer.org/serum-potassium-linked-to-28-day-sepsis-mortality/</guid>

					<description><![CDATA[In a groundbreaking study, researchers have identified a significant link between serum potassium levels and the 28-day mortality rates of elderly patients suffering from sepsis. With an increasing number of sepsis cases reported globally, especially among the elderly population, understanding the risk factors that influence mortality is crucial. The recent multicenter cohort study spearheaded by [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">295819</post-id>	</item>
	</channel>
</rss>
